
Get every episode summarized
Each time Fitt Insider publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
Today I'm joined by Noosheen Hashemi, Founder and CEO of January AI, a precision health company.
January AI has assembled a team of computational, food, translational, and medical scientists to tackle unmet needs in people with or at risk for developing diabetes. Their multi-omic approach synthesizes wearable, food, and microbiome data to make personalized recommendations and products to address hyperglycemia.
In this episode we talk about using glucose monitoring to improve wellbeing. Noosheen explains how January leverages digital twins to create personalized health insights, and she warns against deceptive marketing practices in the digital health space.
In this episode, you'll learn:
- How January balances product development & refinement with product availability
- Noosheen's tips for getting and staying far ahead of your competition
- How January is expanding their customer base and making it easier for people to adopt a healthier lifestyle
Links & Resources
- Subscribe to the Fitt Insider newsletter
- Visit the Fitt Insider jobs board
- View current Fitt Insider investment and get in touch
Noosheen's Links
Get every episode summarized
Each time Fitt Insider publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Fitt Insider

Oura Pauses IPO, Tiny Health Raises $33M, RFK Jr.'s Food Push Stalls
Fitt Insider

Functional Shots Surge, Graza Explores Sale, Surgery Gets Scrutinized
Fitt Insider
358. Kate Ryder, Founder & CEO of Maven Clinic
Fitt Insider

Wearables Funding Surges, Brain Tech Raises $250M, GRAIL Nears FDA Decision
Fitt Insider